MRI of optic neuritis in a rat model

NeuroImage

Volumn 41, Issue 2, 2008, Pages 323-334

  Boretius, Susann ^a   Gadjanski, Ivana ^b   Demmer, Iris ^b   Bähr, Mathias ^b   Diem, Ricarda ^c   Michaelis, Thomas ^a   Frahm, Jens ^a  

^a MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

Author keywords

EAE; Manganese enhanced MRI; MRI; Optic neuritis

Indexed keywords

GADOLINIUM PENTETATE; MANGANESE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXONAL INJURY; BLOOD BRAIN BARRIER; CALCIUM CELL LEVEL; CONTROLLED STUDY; DEMYELINATION; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; IMAGE ENHANCEMENT; IN VIVO STUDY; INFLAMMATION; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PRIORITY JOURNAL; RAT; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY; TISSUE INJURY;

ANIMALS; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; FEMALE; GADOLINIUM DTPA; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; RADIOGRAPHIC IMAGE ENHANCEMENT; RATS;

EID: 44349192055     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2008.02.021     Document Type: Article

References (37)

1. Arnold A.C. Evolving management of optic neuritis and multiple sclerosis. Am. J. Ophthalmol. 139 (2005) 1101-1108
2. Berger C., Hiestand P., Kindler-Baumann D., Rudin M., and Rausch M. Analysis of lesion development during acute inflammation and remission in a rat model of experimental autoimmune encephalomyelitis by visualization of macrophage infiltration, demyelination and blood-brain barrier damage. NMR Biomed. 19 (2006) 101-107
3. Blezer E.L., Bauer J., Brok H.P., Nicolay K., and t Hart B.A. Quantitative MRI-pathology correlations of brain white matter lesions developing in a non-human primate model of multiple sclerosis. NMR Biomed. 20 (2007) 90-103
4. Boorstein J.M., Moonis G., Boorstein S.M., Patel Y.P., and Culler A.S. Optic neuritis: imaging with magnetization transfer. AJR Am. J. Roentgenol. 169 (1997) 1709-1712
5. Boretius S., Schmelting B., Watanabe T., Merkler D., Tammer R., Czeh B., Michaelis T., Frahm J., and Fuchs E. Monitoring of EAE onset and progression in the common marmoset monkey by sequential high-resolution 3D MRI. NMR Biomed. 19 (2006) 41-49
6. Brand-Schieber E., and Werner P. Calcium channel blockers ameliorate disease in a mouse model of multiple sclerosis. Exp. Neurol. 189 (2004) 5-9
7. Coleman M. Axon degeneration mechanisms: commonality amid diversity. Nat. Rev., Neurosci. 6 (2005) 889-898
8. Diem R., Sattler M.B., Merkler D., Demmer I., Maier K., Stadelmann C., Ehrenreich H., and Bahr M. Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis. Brain 128 (2005) 375-385
9. Floris S., Blezer E.L., Schreibelt G., Dopp E., van der Pol S.M., Schadee-Eestermans I.L., Nicolay K., Dijkstra C.D., and de Vries H.E. Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study. Brain 127 (2004) 616-627
10. Frohman E.M., Frohman T.C., Zee D.S., McColl R., and Galetta S. The neuro-ophthalmology of multiple sclerosis. Lancet Neurol. 4 (2005) 111-121
11. Gass A., Filippi M., Rodegher M.E., Schwartz A., Comi G., and Hennerici M.G. Characteristics of chronic MS lesions in the cerebrum, brainstem, spinal cord, and optic nerve on T1-weighted MRI. Neurology 50 (1998) 548-550
12. 2 and extravasated serum albumin. Invest. Ophthalmol. Vis. Sci. 35 (1994) 1114-1123
13. Henkelman R.M., Stanisz G.J., and Graham S.J. Magnetization transfer in MRI: a review. NMR Biomed. 14 (2001) 57-64
14. Hickman S.J., Toosy A.T., Jones S.J., Altmann D.R., Miszkiel K.A., MacManus D.G., Barker G.J., Plant G.T., Thompson A.J., and Miller D.H. Serial magnetization transfer imaging in acute optic neuritis. Brain 127 (2004) 692-700
15. Hickman S.J., Toosy A.T., Jones S.J., Altmann D.R., Miszkiel K.A., MacManus D.G., Barker G.J., Plant G.T., Thompson A.J., and Miller D.H. A serial MRI study following optic nerve mean area in acute optic neuritis. Brain 127 (2004) 2498-2505
16. Hickman S.J., Toosy A.T., Miszkiel K.A., Jones S.J., Altmann D.R., MacManus D.G., Plant G.T., Thompson A.J., and Miller D.H. Visual recovery following acute optic neuritis-a clinical, electrophysiological and magnetic resonance imaging study. J. Neurol. 251 (2004) 996-1005
17. Hobom M., Storch M.K., Weissert R., Maier K., Radhakrishnan A., Kramer B., Bahr M., and Diem R. Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis. Brain Pathol. 14 (2004) 148-157
18. Inglese M., Ghezzi A., Bianchi S., Gerevini S., Sormani M.P., Martinelli V., Comi G., and Filippi M. Irreversible disability and tissue loss in multiple sclerosis: a conventional and magnetization transfer magnetic resonance imaging study of the optic nerves. Arch. Neurol. 59 (2002) 250-255
19. Jackson A., Sheppard S., Laitt R.D., Kassner A., and Moriarty D. Optic neuritis: MR imaging with combined fat-and water-suppression techniques. Radiology 206 (1998) 57-63
20. Kapoor R., Miller D.H., Jones S.J., Plant G.T., Brusa A., Gass A., Hawkins C.P., Page R., Wood N.W., Compston D.A., Moseley I.F., and McDonald W.I. Effects of intravenous methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis. Neurology 50 (1998) 230-237
21. Lee R.R., and Dagher A.P. Low power method for estimating the magnetization transfer bound-pool macromolecular fraction. J. Magn. Reson. Imaging 7 (1997) 913-917
22. Lin Y.J., and Koretsky A.P. Manganese ion enhances T1-weighted MRI during brain activation: an approach to direct imaging of brain function. Magn. Reson. Med. 38 (1997) 378-388
23. Merkler D., Boretius S., Stadelmann C., Ernsting T., Michaelis T., Frahm J., and Bruck W. Multicontrast MRI of remyelination in the central nervous system. NMR Biomed. 18 (2005) 395-403
24. Meyer R., Weissert R., Diem R., Storch M.K., de Graaf K.L., Kramer B., and Bahr M. Acute neuronal apoptosis in a rat model of multiple sclerosis. J. Neurosci. 21 (2001) 6214-6220
25. Natt O., Watanabe T., Boretius S., Frahm J., and Michaelis T. Magnetization transfer MRI of mouse brain reveals areas of high neural density. Magn. Reson. Imaging 21 (2003) 1113-1120
26. Nessler S., Boretius S., Stadelmann C., Bittner A., Merkler D., Hartung H.P., Michaelis T., Bruck W., Frahm J., Sommer N., and Hemmer B. Early MRI changes in a mouse model of multiple sclerosis are predictive of severe inflammatory tissue damage. Brain 130 (2007) 2186-2198
27. Pautler R.G., Silva A.C., and Koretsky A.P. In vivo neuronal tract tracing using manganese-enhanced magnetic resonance imaging. Magn. Reson. Med. 40 (1998) 740-748
28. Qi X., Lewin A.S., Sun L., Hauswirth W.W., and Guy J. Suppression of mitochondrial oxidative stress provides long-term neuroprotection in experimental optic neuritis. Invest. Ophthalmol. Vis. Sci. 48 (2007) 681-691
29. Rocca M.A., Hickman S.J., Bo L., Agosta F., Miller D.H., Comi G., and Filippi M. Imaging the optic nerve in multiple sclerosis. Mult. Scler. 11 (2005) 537-541
30. Smith M.A., and McDonald W.I. The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease. Philos. Trans. R. Soc. Lond., B Biol. Sci. 354 (1999) 1649-1673
31. Truyen L., van Waesberghe J.H., van Walderveen M.A., van Oosten B.W., Polman C.H., Hommes O.R., Ader H.J., and Barkhof F. Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 47 (1996) 1469-1476
32. van Waesberghe J.H., Kamphorst W., De Groot C.J., van Walderveen M.A., Castelijns J.A., Ravid R., Lycklama a Nijeholt G.J., van der Valk P., Polman C.H., Thompson A.J., and Barkhof F. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann. Neurol. 46 (1999) 747-754
33. Watanabe T., Natt O., Boretius S., Frahm J., and Michaelis T. In vivo 3D MRI staining of mouse brain after subcutaneous application of MnCl2. Magn. Reson. Med. 48 (2002) 852-859
34. Yokel R.A., and Crossgrove J.S. Manganese Toxicokinetics at the Blood-Brain Barrier (2004), Health Effects Institute, Bosten MA
35. Youl B.D., Turano G., Miller D.H., Towell A.D., MacManus D.G., Moore S.G., Jones S.J., Barrett G., Kendall B.E., Moseley I.F., Tofts P.S., Halliday A.M., and McDonald W.I. The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. Brain 114 (1991) 2437-2450
36. Youl B.D., Turano G., Towell A.D., Barrett G., MacManus D.G., Moore S.G., Miller D.H., Jones S.J., du Boulay E.P., Kendall B.E., Moseley I.F., and McDonald W.I. Optic neuritis: swelling and atrophy. Electroencephalogr. Clin. Neurophysiol., Suppl. 46 (1996) 173-179
37. Yu X., Wadghiri Y.Z., Sanes D.H., and Turnbull D.H. In vivo auditory brain mapping in mice with Mn-enhanced MRI. Nat. Neurosci. 8 (2005) 961-968